Semler Scientific, Inc. has 14 Schedule 13D or 13G filings on record since 2025-07-16. 3 holders' latest filing reports 5% or more of common stock, $0.001 par value per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Morgan Stanley | 5.8% | 790,603 | SCHEDULE 13G, 2025-08-07 | 2025-06-30 |
| BlackRock, Inc. | 5.7% | 858,705 | SCHEDULE 13G, 2025-10-17 | 2025-09-30 |
| Citadel Securities GP LLC | 5.1% | 697,427 | SCHEDULE 13G, 2025-08-14 | 2025-06-30 |
| Capital Ventures International | 2.6% | 395,307 | SCHEDULE 13G/A, 2025-11-13 | 2025-09-30 |
| Capital International Investors | 2.6% | 385,239 | SCHEDULE 13G/A, 2025-11-13 | 2025-09-30 |
| Ridgeback Capital Investments L.P. | 0% | 0 | SCHEDULE 13G/A, 2025-11-14 | 2025-09-30 |
| Eric Semler | 0% | 0 | SCHEDULE 13D/A, 2026-01-16 | 2026-01-16 |
| William H.C. & Diana Shon Chang Ttee Chang Family Trust U/A/ Dtd 10/23/2006 | 0% | 0 | SCHEDULE 13D/A, 2026-01-16 | 2026-01-16 |
| Weiss Asset Management LP | 0% | 0 | SCHEDULE 13G/A, 2026-05-11 | 2026-03-31 |
Purpose of Transaction (Item 4)
Eric Semler
Item 4. is hereby amended to add the following: On January 16, 2026, (the "Effective Time"), Semler Scientific, Inc. ("Semler Scientific") completed the transactions contemplated by the Agreement and Plan of Merger dated September 22, 2025, as amended by that certain amendment, dated as of December 3, 2025 (the "Merger Agreement"), by and among Semler Scientific, Strive, Inc. ("Strive"), and Strive Merger Sub, Inc., a wholly owned subsidiary of Strive ("Merger Sub"), pursuant to which, among other matters, Merger Sub merged with and into Semler Scientific effective as of January 16, 2026, with Semler Scientific surviving such merger as a direct, wholly owned subsidiary of Strive (the "Merger"). At the Effective Time, each share of Semler Scientific's common stock that was issued and outstanding immediately prior to the Effective Time (except for treasury stock or shares owned by Semler Scientific or Strive (in each case other than in a fiduciary or agency capacity or as a result of debts previously contracted)) was converted into the right to receive 21.05 shares of Strive's Class A Common Stock, plus cash in lieu of fractional shares.Item 4 of the SCHEDULE 13D/A filed 2026-01-16
William H.C. & Diana Shon Chang Ttee Chang Family Trust U/A/ Dtd 10/23/2006
Item 4. is hereby amended to add the following: On January 16, 2026, (the "Effective Time"), Semler Scientific, Inc. ("Semler Scientific") completed the transactions contemplated by the Agreement and Plan of Merger dated September 22, 2025, as amended by that certain amendment, dated as of December 3, 2025 (the "Merger Agreement"), by and among Semler Scientific, Strive, Inc. ("Strive"), and Strive Merger Sub, Inc., a wholly owned subsidiary of Strive ("Merger Sub"), pursuant to which, among other matters, Merger Sub merged with and into Semler Scientific effective as of January 16, 2026, with Semler Scientific surviving such merger as a direct, wholly owned subsidiary of Strive (the "Merger"). At the Effective Time, each share of Semler Scientific's common stock that was issued and outstanding immediately prior to the Effective Time (except for treasury stock or shares owned by Semler Scientific or Strive (in each case other than in a fiduciary or agency capacity or as a result of debts previously contracted)) was converted into the right to receive 21.05 shares of Strive's Class A Common Stock, plus cash in lieu of fractional shares.Item 4 of the SCHEDULE 13D/A filed 2026-01-16
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-16 | Ridgeback Capital Investments L.P. | 6.9% | SCHEDULE 13G |
| 2025-07-16 | BlackRock, Inc. | 4.3% | SCHEDULE 13G/A |
| 2025-08-07 | Morgan Stanley | 5.8% | SCHEDULE 13G |
| 2025-08-14 | Capital Ventures International | 4.4% | SCHEDULE 13G/A |
| 2025-08-14 | Citadel Securities GP LLC | 5.1% | SCHEDULE 13G |
| 2025-09-17 | Capital Ventures International | 5.7% | SCHEDULE 13G |
| 2025-10-17 | BlackRock, Inc. | 5.7% | SCHEDULE 13G |
| 2025-11-13 | Capital Ventures International | 2.6% | SCHEDULE 13G/A |
| 2025-11-13 | Capital International Investors | 2.6% | SCHEDULE 13G/A |
| 2025-11-14 | Ridgeback Capital Investments L.P. | 0% | SCHEDULE 13G/A |
| 2026-01-16 | Eric Semler | 0% | SCHEDULE 13D/A |
| 2026-01-16 | William H.C. & Diana Shon Chang Ttee Chang Family Trust U/A/ Dtd 10/23/2006 | 0% | SCHEDULE 13D/A |
| 2026-02-11 | Weiss Asset Management LP | 5.2% | SCHEDULE 13G |
| 2026-05-11 | Weiss Asset Management LP | 0% | SCHEDULE 13G/A |
Tools for this story
Each opens in a new tab, filled in for Semler Scientific, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.